Sec.20-631-2. Content of a collaborative drug therapy management agreement

A collaborative drug therapy management agreement shall include:

(1) The types of prescriptive authority decisions the pharmacist may make (e.g., initiation, continuation or modification);

(2) Patients who are eligible for treatment;

(3) The types of diseases, drugs, or drug categories involved (there are no limitations on disease states or conditions);

(4) The procedures, decision criteria, plans, or guidelines the pharmacist is to follow when making therapeutic decisions, particularly when initiating or modifying drug therapy;

(5) Required training;

(6) A plan for periodic review, feedback and quality assurance; and

(7) Procedures for documenting prescribing decisions.

(Effective January 2, 2013)